Peter Lu, Partner and Global Head of the China Practice at McDermott Will & Emery, discusses China’s opening of its health industry to international investors.
In this interview, Jean-Marie Dangou from the WHO Regional Office for Africa discusses diabetes in the African region, including lack of access to treatment and ongoing action to solve this.
This article considers the increasing political interest in the use of Artificial Intelligence (AI) in healthcare and considers how data protection legislation may help to build greater understanding and trust.
A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
Frédéric Destrebecq, Executive Director of the European Brain Council explains the importance of tackling the growing burden of brain disorders in Europe.
Welcome extra funding for capital, workforce and social care will plug gaps in the short term but falls short of what’s needed, says NHS Confederation.
Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
The European Red Cell Society’s met the partners of the EU intellectual training network RELEVANCE at Mount of Truth in Ascona, Switzerland to discuss the latest progress.
New research shows over half of employees who took mental health days faked a physical illness to explain their absence, despite stress from work souring relationships and sleep patterns for many.
Jo Sellick discusses his opinion on the future of the NHS, which bravely faces Brexit and Boris Johnson, migration limitations and an ageing population.
Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.
With diabetes on the increase in the UK, Dr Louise Gow, Specialist Lead for Eye Health at The Royal National Institute of Blind People (RNIB) explains more about the condition and how it can affect the eyes.
